CACNA1A Haploinsufficiency Impairs Synaptic Function and Increases Neuronal Excitability

Overview

CACNA1A haploinsufficiency in human iPSC-derived glutamatergic neurons leads to synaptic deficits characterized by reduced synaptic number and strength, alongside increased intrinsic neuronal excitability. These changes are mediated by altered AMPA receptor composition and diminished potassium channel function, revealing novel mechanisms underlying CACNA1A-related neurodevelopmental phenotypes.

Background

CACNA1A encodes the α1 subunit of P/Q-type voltage-gated calcium channels critical for synaptic neurotransmission and neuronal excitability. Haploinsufficiency of CACNA1A is linked to a spectrum of clinical phenotypes including cerebellar ataxia, epilepsy, and intellectual disability. While animal models have elucidated some cerebellar mechanisms, the cortical effects of CACNA1A loss-of-function remain less understood. Human induced pluripotent stem cell (iPSC) models provide a platform to investigate these mechanisms in cortical glutamatergic neurons.

Data Highlights

Using CRISPR/Cas9, isogenic human iPSC lines with monoallelic CACNA1A frameshift mutations were generated and differentiated into cortical glutamatergic neurons. Electrophysiological recordings revealed altered network synchronization and increased non-synaptic activity. Gene expression analyses showed reduced potassium channel expression. Pharmacological modulation with 4-aminopyridine partially rescued network phenotypes, and positive modulation of small conductance calcium-activated potassium channels reversed electrophysiological abnormalities.

Key Findings

• CACNA1A+/− neurons exhibit reduced synaptic number and strength with increased contribution of GluA2-lacking AMPA receptors.
• Neuronal networks show altered synchronization and increased intrinsic excitability despite synaptic deficits.
• Potassium channel function and expression are diminished, contributing to enhanced excitability.
• Pharmacological intervention with 4-aminopyridine partially mitigates network dysfunction.
• Positive modulation of small conductance calcium-activated potassium channels reverses electrophysiological abnormalities.
• The iPSC-derived neuronal model effectively recapitulates CACNA1A haploinsufficiency phenotypes and offers a platform for therapeutic discovery.

Clinical Implications

These findings highlight the dual impact of CACNA1A haploinsufficiency on synaptic transmission and intrinsic excitability, suggesting that therapeutic strategies should target both synaptic deficits and potassium channel dysfunction. Agents like 4-aminopyridine and modulators of calcium-activated potassium channels may offer clinical benefit in managing symptoms associated with CACNA1A-related disorders. This human neuronal model provides a valuable tool for preclinical testing of such interventions.

Conclusion

The study establishes a human iPSC-derived neuronal model of CACNA1A haploinsufficiency that reveals synaptic impairments coupled with increased neuronal excitability due to potassium channel deficits. These insights advance understanding of CACNA1A-related pathophysiology and support targeted therapeutic development.

References

1. Hommersom et al. 2024 -- Deficiency of CACNA1A Results in Impaired Synaptic Activity and Enhanced Neuronal Excitability